Infection control is critically important in bone marrow biopsy procedures, particularly for immunocompromised patients, where contamination can lead to severe infectious complications. Jiangsu Changfeng Medical Industry Co., Ltd. produces bone marrow biopsy needles with integrated infection control features to minimize risks and support safe clinical practice. Our bone marrow biopsy needles are single‑use, terminally sterilized, and individually packaged to eliminate cross‑contamination between patients. Secure, tamper‑evident packaging ensures integrity until use. Smooth, non‑porous needle surfaces resist microbial adhesion and biofilm formation, supporting infection prevention. Medical‑grade materials withstand standard disinfectants without degradation, maintaining safety during clinical workflows. Color‑coded, ergonomic hubs reduce handling complexity and touch contamination in aseptic fields. In neutropenic patients undergoing leukemia evaluation, our sterile needles help prevent severe local or systemic infections. In hematopoietic stem cell transplant recipients, they support safe diagnostic sampling during periods of severe immunocompromise. In outpatient hematology clinics, they ensure consistent infection control without complex reprocessing. Changfeng’s manufacturing facilities adhere to strict cleanroom standards and microbial control protocols. Each batch undergoes sterility validation and quality testing to ensure compliance with international norms. As a healthcare‑focused enterprise, we prioritize patient safety through robust infection control design. Our commitment to the Healthy China strategy drives continuous improvement in safety and hygiene. For infection control specifications, sterility certifications, packaging details, and pricing of our bone marrow biopsy needles, please contact our infection control specialists.